Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Trends in Cancer
|
July 19, 2017
Targeting ATF5 in Cancer
James M Angelastro
Molecular Cancer Research : MCR
|
July 29, 2010
Overexpression of CD133 promotes drug resistance in C6 glioma cells
James M Angelastro, Michael W Lamé
Neurochemical Research
|
December 13, 2005
You can't go home again: transcriptionally driven alteration of cell signaling by NGF
Lloyd A Greene, James M Angelastro
Oncotarget
|
November 16, 2017
The transcription factor ATF5: role in cellular differentiation, stress responses, and cancer
Thomas K Sears, James M Angelastro
Brain Sciences
|
September 28, 2024
Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases
Adaleiz Ore, James M Angelastro, Cecilia Giulivi
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 22, 2002
The basic region and leucine zipper transcription factor MafK is a new nerve growth factor-responsive immediate early gene that regulates neurite outgrowth
Béata Töröcsik, James M Angelastro, Lloyd A Greene
BMC Neuroscience
|
April 2, 2002
Nerve growth factor selectively regulates expression of transcripts encoding ribosomal proteins
James M Angelastro, Béata Töröcsik, Lloyd A Greene
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 6, 2025
CYP2B6 downregulation by cell-penetrating dominant-negative activating transcription factor 5 peptide in glioblastoma cells
Ji Yae Lee, Orli Algranatti, James M Angelastro
Journal of Neurochemistry
|
December 3, 2008
The transcription factor ATF5: role in neurodevelopment and neural tumors
Lloyd A Greene, Hae Young Lee, James M Angelastro
Neurobiology of Disease
|
January 15, 2005
Analysis of gene expression changes in a cellular model of Parkinson disease
Elizabeth J Ryu, James M Angelastro, Lloyd A Greene
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Trends in Cancer
|
July 19, 2017
Targeting ATF5 in Cancer
James M Angelastro
Molecular Cancer Research : MCR
|
July 29, 2010
Overexpression of CD133 promotes drug resistance in C6 glioma cells
James M Angelastro, Michael W Lamé
Neurochemical Research
|
December 13, 2005
You can't go home again: transcriptionally driven alteration of cell signaling by NGF
Lloyd A Greene, James M Angelastro
Oncotarget
|
November 16, 2017
The transcription factor ATF5: role in cellular differentiation, stress responses, and cancer
Thomas K Sears, James M Angelastro
Brain Sciences
|
September 28, 2024
Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases
Adaleiz Ore, James M Angelastro, Cecilia Giulivi
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 22, 2002
The basic region and leucine zipper transcription factor MafK is a new nerve growth factor-responsive immediate early gene that regulates neurite outgrowth
Béata Töröcsik, James M Angelastro, Lloyd A Greene
BMC Neuroscience
|
April 2, 2002
Nerve growth factor selectively regulates expression of transcripts encoding ribosomal proteins
James M Angelastro, Béata Töröcsik, Lloyd A Greene
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 6, 2025
CYP2B6 downregulation by cell-penetrating dominant-negative activating transcription factor 5 peptide in glioblastoma cells
Ji Yae Lee, Orli Algranatti, James M Angelastro
Journal of Neurochemistry
|
December 3, 2008
The transcription factor ATF5: role in neurodevelopment and neural tumors
Lloyd A Greene, Hae Young Lee, James M Angelastro
Neurobiology of Disease
|
January 15, 2005
Analysis of gene expression changes in a cellular model of Parkinson disease
Elizabeth J Ryu, James M Angelastro, Lloyd A Greene
Page
of 4